Industry Reports
Merck to Hold Investor Briefing at 2016 ASCO Annual Meeting
Merck known as MSD outside the United States and Canada, announced that Dr. Roger M. Perlmutter, president, Merck Research Laboratories, will present an overview...
Press Releases
Allergan receives US FDA marketing approval for Juvederm Volbella XC for use in lips & perioral rhytids
Allergan plc a leading global pharmaceutical company announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market...
Press Releases
Bayer collaborates with U.S. National Surgical Adjuvant Breast and Bowel Project to Investigate Stivarga as Adjuvant Therapy in Colon Cancer
Study will include patients with Stage IIIB and IIIC colon cancer who have undergone complete surgical resection of primary tumor and received standard adjuvant...
Research Insight
Mylan Launches First Generic of Nuvigil Tablets
Mylan N.V. announced the U.S. launch of Armodafinil Tablets, 50 mg, 150 mg, 250 mg, a generic version of Cephalon's Nuvigil®. Mylan received final...
News
Biogens Investigational Alzheimers Disease Treatment Aducanumab Accepted into European Medicines Agencys PRIME Program
Biogen announced that aducanumab, its investigational treatment for early Alzheimer’s disease (AD), was accepted into the European Medicines Agency’s (EMA) Priority Medicines (PRIME) program....
Press Releases
EC Approves the AbbVies IMBRUVICA for First-Line Treatment of Patients with Chronic Lymphocytic Leukemia
AbbVie a global biopharmaceutical company announced that the EC approved IMBRUVICA® (ibrutinib) as a first-line treatment option for adult patients with chronic lymphocytic leukemia...
News
Otsuka Holdings Announces New, Additional Certification Under “ISO 22301” (International Standard for Business Continuity Management)
Expands scope of certification to include additional Otsuka Group products, reflecting the company’s improved resiliency and continuous operational capability during unexpected events. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read